Citigroup’s Autolus Therapeutics AUTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.71K | Buy |
3,822
+659
| +21% | +$1.5K | ﹤0.01% | 4470 |
|
|
2025
Q1 | $4.9K | Sell |
3,163
-167
| -5% | -$259 | ﹤0.01% | 4493 |
|
|
2024
Q4 | $7.83K | Sell |
3,330
-214
| -6% | -$503 | ﹤0.01% | 4556 |
|
|
2024
Q3 | $12.9K | Sell |
3,544
-13,408
| -79% | -$48.7K | ﹤0.01% | 4457 |
|
|
2024
Q2 | $59K | Sell |
16,952
-65,633
| -79% | -$228K | ﹤0.01% | 3762 |
|
|
2024
Q1 | $527K | Buy |
82,585
+80,040
| +3,145% | +$511K | ﹤0.01% | 2817 |
|
|
2023
Q4 | $16.4K | Buy |
+2,545
| New | +$16.4K | ﹤0.01% | 4296 |
|
|
2023
Q1 | – | Sell |
-92
| Closed | -$175 | – | 4734 |
|
|
2022
Q4 | $175 | Sell |
92
-666
| -88% | -$1.27K | ﹤0.01% | 4803 |
|
|
2022
Q3 | $2K | Sell |
758
-199
| -21% | -$525 | ﹤0.01% | 4669 |
|
|
2022
Q2 | $3K | Sell |
957
-279
| -23% | -$875 | ﹤0.01% | 4968 |
|
|
2022
Q1 | $5K | Sell |
1,236
-509
| -29% | -$2.06K | ﹤0.01% | 4977 |
|
|
2021
Q4 | $9K | Sell |
1,745
-1,454
| -45% | -$7.5K | ﹤0.01% | 4797 |
|
|
2021
Q3 | $21K | Sell |
3,199
-72
| -2% | -$473 | ﹤0.01% | 4459 |
|
|
2021
Q2 | $22K | Buy |
3,271
+2,620
| +402% | +$17.6K | ﹤0.01% | 4560 |
|
|
2021
Q1 | $4K | Sell |
651
-366
| -36% | -$2.25K | ﹤0.01% | 5261 |
|
|
2020
Q4 | $9K | Sell |
1,017
-1,376
| -58% | -$12.2K | ﹤0.01% | 4897 |
|
|
2020
Q3 | $28K | Sell |
2,393
-132
| -5% | -$1.55K | ﹤0.01% | 3762 |
|
|
2020
Q2 | $40K | Sell |
2,525
-2,384
| -49% | -$37.8K | ﹤0.01% | 3879 |
|
|
2020
Q1 | $29K | Buy |
4,909
+2,868
| +141% | +$16.9K | ﹤0.01% | 4155 |
|
|
2019
Q4 | $27K | Buy |
2,041
+1,349
| +195% | +$17.8K | ﹤0.01% | 4348 |
|
|
2019
Q3 | $9K | Buy |
692
+228
| +49% | +$2.97K | ﹤0.01% | 4603 |
|
|
2019
Q2 | $7K | Buy |
464
+199
| +75% | +$3K | ﹤0.01% | 4811 |
|
|
2019
Q1 | $8K | Buy |
+265
| New | +$8K | ﹤0.01% | 4791 |
|